Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
Can Recursion accelerate the time frame for drug discovery? Last year, Recursion announced that tech giant Nvidia invested $50 million into its operations. Together, the businesses are working on drug ...
Recursion Pharmaceuticals (RXRX Quick Quote RXRX - Free Report) shares soared 5.8% in the last trading session to close at $5.84. The move was backed by solid volume with far more shares changing ...
Recursion Pharmaceuticals (RXRX) closed the last trading session at $8.59, gaining 20% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
That brings us to Recursion Pharmaceuticals (RXRX 3.04%), a biotech company specializing in drug discovery using artificial intelligence (AI). At least one notable name in the investing world thinks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results